DISCOUNT ZERTIFIKAT - NOVO NORDISK ADR B Share Price

Certificat

DE000ME85RV3

Real-time Bid/Ask 17:05:30 03/07/2024 BST
105.11 EUR / 105.13 EUR -2.02% Intraday chart for DISCOUNT ZERTIFIKAT - NOVO NORDISK ADR B
Current month-0.43%
1 month+3.50%
Date Price Change
03/07/24 106.2 -1.02%
02/07/24 107.3 -0.89%
01/07/24 108.2 +0.46%
28/06/24 107.8 -0.19%
27/06/24 108 -0.18%

Delayed Quote Börse Stuttgart

Last update July 03, 2024 at 03:53 pm

More quotes

Static data

Product typeCertificats Discount
Buy / SellCALL
Underlying NOVO NORDISK A/S
Issuer Morgan Stanley
WKN ME85RV
ISINDE000ME85RV3
Date issued 05/02/2024
Cap 130 $
Last trading day 20/06/2025
Maturity 20/06/2025 (352 Days)
Parity 1 : 1
Emission price 95.89
Emission volume N/A
Payment day 27/06/2025
Bonus-
Settlement règlement en espèces
Currency EUR

Technical Indicators

Discount (ask) 17.58 %
Sideways yield 14.44 %
Sideways yield pa 14.97 %
Outperformance point 157.7 $
Break even 113.60 €
Highest since issue 108.8
Lowest since issue 94.34
Spread 0.03
Spread %0.03%
Distance Cap 6.975 $
Distance Cap %+5.09%
Max. earning 15.19
Max. earning % 14.44 %

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
993.5 DKK
Average target price
952.2 DKK
Spread / Average Target
-4.16%
Consensus